Cited by 358Neuropeptides and Animal PhysiologyNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 311 of the 311 references it cites were found in a registry or an index.

The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y

Kask, Ants, Harro, Jaanus, von Hörsten, Stephan, Redrobe, John P., Dumont, Yvan, Quirion, Rémi·2002·Neuroscience & Biobehavioral Reviews

DOI 10.1016/s0149-7634(01)00066-5

Open this paper in CoChat — free account

Abstract

This review aims to give a brief overview of NPY receptor distribution and physiology in the brain and summarizes series of studies, test by test and region by region, aimed at identification receptor subtypes and neuronal circuitry mediating anxiolytic-like effects of NPY. We conclude that from four known NPY receptor subtypes in the rat (Y(1), Y(2), Y(4), Y(5)), only the NPY Y(1) receptor can be linked to anxiety-regulation with certainty in the forebrain, and that NPY Y(2) receptor may have a role in the pons. Microinjection studies with NPY and NPY receptor antagonists support the hypothesis that the amygdala, the dorsal periaqueductal gray matter, dorsocaudal lateral septum and locus coeruleus form a neuroanatomical substrate that mediates anxiolytic-like effects of NPY. The release of NPY in these areas is likely phasic, as NPY receptor antagonists are silent on their own. However, constant NPY-ergic tone seems to exist in the dorsal periaqueductal gray, the only brain region where NPY Y(1) receptor antagonists had anxiogenic-like effects. We conclude that endogenous NPY has an important role in reducing anxiety and serves as a physiological stabilizer of neural activity in circuits involved in the regulation of arousal and anxiety.

Integrity signals

Registry

Crossref · 10.1016/s0149-7634(01)00066-5

Cites

311 of 311 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Items 201–311 of 311

The Neuropeptide Y Y1 Antagonist, 1229U91, A Potent Agonist for the Human Pancreatic Polypeptide-Preferring (NPY Y4) Receptor
Schober, D. A., van Abbema, A. M., Smiley, D. L., et al. (1998) · Peptides · doi:10.1016/s0196-9781(97)00455-5 · Cited by 67
Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats.
Kask, A., Rägo, L., & Harro, J. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00076-7 · Cited by 67
Self-citation
Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release
Small, C. J., Morgan, D. G. A., Meeran, K. M., Heath, M., Gunn, I., Edwards, C. M. B., Gardiner, J., Taylor, G. M., Hurley, J. D., Rossi, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11686 · Cited by 67
[ 125 I]Leu 31 , Pro 34 -PYY is a High Affinity Radioligand for Rat PP1/Y4 and Y1 Receptors: Evidence for Heterogeneity in Pancreatic Polypeptide Receptors
Gehlert, D. R., Schober, D. A., Gackenheimer, S. L., Beavers, L. S., Gadski, R. A., Lundell, I., & Larhammar, D. (1997) · Peptides · doi:10.1016/s0196-9781(96)00346-4 · Cited by 64
Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions
Smith-White, M. A., Hardy, T. A., Brock, J. A., & Potter, E. K. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703879 · Cited by 64
A novel neuropeptide Y analog, N-acetyl [Leu28, Leu31]neuropeptide Y-(24–36), with functional specificity for the presynaptic (Y2) receptor
Potter, E. K., Barden, J. A., McCloskey, M. J. D., SELBIE, L. A., Tseng, A., Herzog, H., & Shine, J. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90148-1 · Cited by 63
Stress-induced changes of circulating neuropeptide Y in the rat: comparison with catecholamines
Castagné, V., Corder, R., Gaillard, R. C., & Mormède, P. (1987) · Regulatory Peptides · doi:10.1016/0167-0115(87)90074-7 · Cited by 62
NPY-induced feeding involves the action of a Y1-like receptor in rodents
Kanatani, A., Itô, J., Ishihara, A., Iwaasa, H., Fukuroda, T., Fukami, T., MacNeil, D. J., der Ploeg, L. H. T. V., & Ihara, M. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00096-2 · Cited by 61
Chronic Blockade of the Melanocortin 4 Receptor Subtype Leads to Obesity Independently of Neuropeptide Y Action, with No Adverse Effects on the Gonadotropic and Somatotropic Axes
Raposinho, P., Castillo, E., d’Allèves, V., Broqua, P., Pralong, F. P., & Aubert, M. L. (2000) · Endocrinology · doi:10.1210/endo.141.12.7842 · Cited by 60
Hypothalamic Neuropeptide Y Messenger Ribonucleic Acid Levels in Pre‐Obese and Genetically Obese (fa/fa) Rats; Potential Regulation Thereof by Corticotropin‐Releasing Factor
van Huijsduijnen, O. B.-H., Rohner‐Jeanrenaud, F., & Jeanrenaud, B. (1993) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1993.tb00498.x · Cited by 59
Corticotropin-releasing factor receptor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats
Smagin, G. N., Harris, R. B. S., & Ryan, D. H. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13254-7 · Cited by 59
Agonist and antagonist activities on human NPFF2 receptors of the NPY ligands GR231118 and BIBP3226
Mollereau, C., Gouardères, C., Dumont, Y., et al. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704049 · Cited by 59
Self-citation
Behavioral sensitization to nicotine is associated with behavioral disinhibition; counteraction by citalopram
Olausson, P., Engel, J. A., & Söderpalm, B. (1999) · Psychopharmacology · doi:10.1007/s002130050869 · Cited by 59
Neuropeptide Y potentiates via Y2-receptors the inhibitory effect of noradrenaline in rat locus coeruleus neurones
Illés, P., Finta, E. P., & Nieber, K. (1993) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00173217 · Cited by 58
α-Helical CRF9-41 prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats
Kask, A., Rägo, L., & Harro, J. (1997) · Neuroreport · doi:10.1097/00001756-199711100-00044 · Cited by 57
Self-citation
The Geller-Seifter conflict paradigm with incremental shock
Pollard, G. T., & Howard, J. L. (1979) · Psychopharmacology · doi:10.1007/bf00427123 · Cited by 57
Characterization of a Selective Antagonist of Neuropeptide Y at the Y2 Receptor
Grouzmann, E., Buclin, T., Martire, M., Cannizzaro, C., Dörner, B., Razaname, A., & Mutter, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7699 · Cited by 56
Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosion in the rat
Heilig, M. A., & Murison, R. C. C. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90191-9 · Cited by 56
Examination of the role of the amphipathic .alpha.-helix in the interaction of neuropeptide Y and active cyclic analogs with cell membrane receptors and dimyristoylphosphatidylcholine
McLean, L. R., Buck, S. H., & Krstenansky, J. L. (1990) · Biochemistry · doi:10.1021/bi00460a009 · Cited by 56
Immunohistochemical localization of the neuropeptide Y Y1 receptor in rat central nervous system
Migita, K., Loewy, A. D., Ramabhadran, T. V., Krause, J. E., & Waters, S. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03092-4 · Cited by 55
Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockade
Zuana, O. D., Sadlo, M., Germain, M., et al. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801472 · Cited by 55
NPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test
Kask, A., Rägo, L., & Harro, J. (1998) · Neuroreport · doi:10.1097/00001756-199808240-00005 · Cited by 54
Self-citation
Neuropeptide Y alters sedation through a hypothalamic Y1‐mediated mechanism
Naveilhan, P., Canals, J. M., Valjakka, A., Vartiainen, J., Arenas, E., & Ernfors, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01601.x · Cited by 54
The cloned guinea pig pancreatic polypeptide receptor Y4 resembles more the human Y4 than does the rat Y4
Eriksson, H., Berglund, M. M., Holmberg, S. K. S., Kahl, U., Gehlert, D. R., & Larhammar, D. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00050-0 · Cited by 53
Molecular biology and pharmacology of multiple NPY Y5 receptor species homologs
Borowsky, B., Walker, M. W., Bard, J., Weinshank, R. L., Laz, T. M., Vaysse, P. J. ‐., Branchek, T. A., & Gerald, C. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00052-4 · Cited by 53
A theory of anxiety: the role of the limbic system.
Ja, G. (1983) · PubMed · Cited by 52
Neuropeptide Y inhibits glutamate release and long-term potentiation in rat dentate gyrus
Whittaker, E. A., Vereker, E., & Lynch, M. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01302-5 · Cited by 52
Conservation of Expression of Neuropeptide Y5 Receptor between Human and Rat Hypothalamus and Limbic Regions Suggests an Integral Role in Central Neuroendocrine Control
Nichol, K. A., Morey, A. L., Couzens, M., Shine, J., Herzog, H., & Cunningham, A. M. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-23-10295.1999 · Cited by 51
Comparison of [125I]Bolton-Hunter neuropeptide Y binding sites in the forebrain of various mammalian species
Martel, J., St‐Pierre, S., Bédard, P. J., et al. (1987) · Brain Research · doi:10.1016/0006-8993(87)90617-2 · Cited by 51
An excitatory amino acid projection from ventromedial hypothalamus to periaqueductal gray in the rat: Autoradiographic and electrophysiological evidence
Beart, P. M., Nicolopoulos, L. S., West, D. C., & Headley, P. M. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90352-7 · Cited by 51
Antinociceptive effects of neuropeptide Y and related peptides in mice
Broqua, P., Wettstein, J. G., Rocher, M., et al. (1996) · Brain Research · doi:10.1016/0006-8993(96)00262-4 · Cited by 51
The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism
Morgan, D. G. A., Small, C. J., Abusnana, S., Turton, M. D., Gunn, I., Heath, M., Rossi, M., Goldstone, A. P., O’Shea, D., Meeran, K. M., et al. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00091-3 · Cited by 50
Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls.
Gjerris, A., Widerlöv, E., Werdelin, L., & Ekman, R. (1992) · PubMed Central · Cited by 49
Molecular Genetic Analysis of a Human Neuropeptide Y Receptor
Rose, P. M., Lynch, J. S., Frazier, S. T., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3622 · Cited by 49
Isolation and characterization of neuropeptide Y from porcine intestine
Tatemoto, K., Siimesmaa, S., Jörnvall, H., et al. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80216-7 · Cited by 48
Neuropeptide Y produces anxiolytic effects in spontaneously hypertensive rats
Pich, E. M., Agnati, L. F., Zini, I., Marrama, P., & Carani, C. (1993) · Peptides · doi:10.1016/0196-9781(93)90065-o · Cited by 48
Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y1 receptor antagonist BIBO 3304
Kask, A., & Harro, J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00199-9 · Cited by 48
Self-citation
Elevated plasma levels of neuropeptide Y in patients with panic disorder
Boulenger, J.-P., Jerabek, I., JOLICOEUR, F. B., et al. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.1.114 · Cited by 48
Neuropeptide Y Y5 receptor protein in the cortical/limbic system and brainstem of the rat: expression on γ-aminobutyric acid and corticotropin-releasing hormone neurons
Grove, K. L., Campbell, R. E., ffrench-Mullen, J. M. H., Cowley, M. A., & Smith, M. S. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00308-0 · Cited by 47
Design, synthesis and SAR of a series of 2-substituted 4-amino-quinazoline neuropeptide Y Y5 receptor antagonists
Rueeger, H., Rigollier, P., Yamaguchi, Y., et al. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00177-3 · Cited by 47
α-Substituted N -(Sulfonamido)alkyl-β-aminotetralins: Potent and Selective Neuropeptide Y Y5 Receptor Antagonists
Youngman, M. A., McNally, J. J., Lovenberg, T. W., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990468g · Cited by 45
Modulation of innate immune functions by intracerebroventricularly applied neuropeptide Y: Dose and time dependent effects
von Hörsten, S., Ballof, J., Helfritz, F., Nave, H., Meyer, D., Schmidt, R. E., Stalp, M., Klemm, A., Tschernig, T., & Pabst, R. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00349-x · Cited by 45
Anxiolytic-like effect of the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA) on rat exploratory activity
Sherif, F. M., Harro, J., Elhwuegi, A. S., & Oreland, L. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90226-7 · Cited by 44
Self-citation
Characterization of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sites
Statnick, M. A., Schober, D. A., Gackenheimer, S. L., Johnson, D., Beavers, L. S., Mayne, N. G., Burnett, J. P., Gadski, R. A., & Gehlert, D. R. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00855-5 · Cited by 42
1,3-Disubstituted Benzazepines as Novel, Potent, Selective Neuropeptide Y Y1 Receptor Antagonists
Murakami, Y., Hara, H., Okada, T., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990044m · Cited by 41
Differences in genetic predisposition to high anxiety in two inbred rat strains: role of substance P, diazepam binding inhibitor fragment and neuropeptide Y
Sudakov, S. K., Медведева, О. Ф., Русакова, И. В., et al. (2001) · Psychopharmacology · doi:10.1007/s002130000651 · Cited by 40
Neuropeptide Y-induced contraction is mediated by neuropeptide Y Y2 and Y4 receptors in the rat colon
Pheng, L.-H., Perron, A., Quirion, R., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00296-4 · Cited by 40
Self-citation
Ultrastructural analysis of ventrolateral periaqueductal gray projections to the A7 catecholamine cell group
Bajic, D., Bockstaele, E. J. V., & Proudfit, H. K. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00052-5 · Cited by 40
Neuropeptide Y and Drug Development
Michel, M. C. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01178-x · Cited by 40
Neuropeptide Y in the specific hypothalamic nuclei of rats treated neonatally with monosodium glutamate
Abe, M., Saito, M., & Shimazu, T. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90218-o · Cited by 39
Neuropeptide Y induced increase of cytosolic and nuclear Ca2+in heart and vascular smooth muscle cells
Jacques, D., Sader, S., El‐Bizri, N., et al. (2000) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y99-127 · Cited by 39
Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices
Weiser, T. W., Wieland, H., & Doods, H. N. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00478-7 · Cited by 39
Evolution of the Neuropeptide Y Family and Its Receptorsa
Larhammar, D., Söderberg, C., & Lundell, I. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10729.x · Cited by 39
Measurement of Exploratory Behavior in Rodents
Harro, J. (1993) · Methods in neurosciences · doi:10.1016/b978-0-12-185277-1.50028-9 · Cited by 39
Self-citation
Psychoneuroendocrine profile associated with hypertension or hyperactivity in spontaneously hypertensive rats
Castanon, N., Hendley, E. D., Fan, X. M., et al. (1993) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1993.265.6.r1304 · Cited by 39
Paradigms for the Study of Behavior
(1993) · Methods in neurosciences · doi:10.1016/c2013-0-10537-5 · Cited by 38
The Effect of Acute and Chronic Restraint on the Central Expression of Prepro‐Neuropeptide Y mRNA in Normotensive and Hypertensive Rats
Sweerts, B., Jarrott, B., & Lawrence, A. J. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00674.x · Cited by 38
Neuropeptide Y and sigma ligand (JO 1784) suppress stress-induced colonic motor disturbances in rats through sigma and cholecystokinin receptors.
Gué, M., Junien, J., Rio, C. D., et al. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11154-3 · Cited by 38
Brain NPY Y1 receptors rapidly mediate the behavioral response to novelty and a compartment-specific modulation of granulocyte function in blood and spleen
von Hörsten, S., Exton, N. G., Exton, M. S., Helfritz, F., Nave, H., Ballof, J., Stalp, M., & Pabst, R. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00772-0 · Cited by 37
Effects of septal lesions on fear-potentiated startle, and on the anxiolytic effects of buspirone and diazepam
Melia, K. R., & Davis, M. (1991) · Physiology & Behavior · doi:10.1016/0031-9384(91)90286-w · Cited by 36
Neuropeptide Y reverses corticotropin-releasing hormone- and psychological stress-caused shortening of sodium pentobarbital-induced sleep in rats
Yamada, K., Shibasaki, T., Tsumori, C., et al. (1996) · Brain Research · doi:10.1016/0006-8993(96)00405-2 · Cited by 36
Plasma Neuropeptide Y (NPY) Increases in Humans in Response to the α2 Antagonist Yohimbine
Rasmusson, A. M. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00199-1 · Cited by 36
Molecular cloning, organization and localization of the gene for the mouse neuropeptide Y-Y5 receptor1The nucleotide sequence(s) reported in this paper have been submitted to the GenBank/EMBL Data Bank under the accession number(s) AB001346.1
Nakamura, M., Yokoyama, M., Watanabe, H., et al. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00131-4 · Cited by 35
Chronic modulation of the GABAA receptor complex regulates Y1 receptor gene expression in the medial amygdala of transgenic mice
Oberto, A., Panzica, G., Altruda, F., et al. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00129-x · Cited by 35
Conditioned fear-induced changes in neuropeptide Y-like immunoreactivity in rats: the effect of diazepam and buspirone
Krysiak, R. G., Obuchowicz, E., & Herman, Z. S. (2000) · Neuropeptides · doi:10.1054/npep.2000.0804 · Cited by 35
High levels of specific neuropeptide Y/pancreatic polypeptide receptors in the rat hypothalamus and brainstem
Trinh, T., Dumont, Y., & Quirion, R. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00863-1 · Cited by 35
Self-citation
Inhibitory effects of neuropeptide Y (NPY) on CRF and stress-induced cecal motor response in rats
Jiménez, M., & Bueno, L. P. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90321-h · Cited by 34
Depression by neuropeptide Y of noradrenergic inhibitory postsynaptic potentials of locus coeruleus neurones
Finta, E. P., Regenold, J. T., & Illés, P. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00171093 · Cited by 33
Antinociceptive effects induced by intra-periaqueductal grey administration of neuropeptide Y in rats
Wang, J., Lundeberg, T., & Yu, L. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02408-7 · Cited by 33
Aminopyrazoles with high affinity for the human neuropeptide Y5 receptor
Kordik, C. P., Luo, C., Zanoni, B. C., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00448-6 · Cited by 32
Neuropeptide Y attenuates the effect of locus coeruleus denervation by DSP-4 treatment on social behaviour in the rat
Kask, A., Eller, M. M., Oreland, L., & Harro, J. (2000) · Neuropeptides · doi:10.1054/npep.1999.0788 · Cited by 31
Self-citation
GABAergic and NPY-Y1 network in the medial amygdala: a neuroanatomical basis for their functional interaction
Oberto, A., Panzica, G., Altruda, F., & Eva, C. E. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00109-5 · Cited by 31
Preferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurones and cloning of the rat Y2 receptor
St‐Pierre, J., Dumont, Y., Nouel, D., Herzog, H., Hamel, É., & Quirion, R. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701589 · Cited by 30
Self-citation
The neuropeptide Y Y1 receptor selective radioligand, [125I][Leu31,Pro34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide 1 receptors
Gehlert, D. R., Gackenheimer, S. L., Schober, D. A., et al. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00797-2 · Cited by 28
Neuropeptide Y Y1 receptor antagonist BIBP3226 produces conditioned place aversion in rats
Kask, A., Kivastik, T., Rägo, L., & Harro, J. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00029-9 · Cited by 28
Self-citation
Reciprocal connections of lateral septal neurons and neurons in the lateral hypothalamus in the rat: A combined phaseolus vulgaris-leucoagglutinin and Fluoro-Gold immunocytochemical study
Deller, T., Léránth, C., & Frotscher, M. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90430-8 · Cited by 26
Differential Effects of Cohort Removal Stress on the Acoustic Startle Response of the Roman/Verh Rat Strains
Aguilar, R., Gil, L., Tobeña, A., et al. (2000) · Behavior Genetics · doi:10.1023/a:1002042711672 · Cited by 26
Synaptology and origin of somatostatin fibers in the rat lateral septal area: convergent somatostatinergic and hippocampal inputs of somatospiny neurons
Jakab, R. L., & Léránth, C. (1991) · Brain Research · doi:10.1016/0006-8993(91)91743-k · Cited by 25
Expression of neurotrophins in hippocampal interneurons immunoreactive for the neuropeptides somatostatin, neuropeptide-Y, vasoactive intestinal polypeptide and cholecystokinin
Pascual, M., Acsády, L., Rocamora, N., Freund, T. F., & Soriano, E. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00391-1 · Cited by 23
Centrally applied NPY mimics immunoactivation induced by non-analgesic doses of met-enkephalin
von Hörsten, S., Nave, H., Ballof, J., et al. (1998) · Neuroreport · doi:10.1097/00001756-199812010-00021 · Cited by 23
Effect of peptide YY (PYY) on food-associated conflict1
HAGAN, M., & Moss, D. E. (1995) · Physiology & Behavior · doi:10.1016/0031-9384(95)00100-w · Cited by 22
Cardiovascular Actions of Neuropeptide Y and Social Stress
Klemfuss, H., Southerland, S., & Britton, K. T. (1998) · Peptides · doi:10.1016/s0196-9781(97)00266-0 · Cited by 22
Effect on nociception of intracerebroventricular administration of low doses of neuropefitde y in mice
Fernández, M. L. M., Gibert‐Rahola, J., Chover, A. J., et al. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00244-5 · Cited by 22
Neuropeptide Y induced increase of cytosolic and nuclear Ca2+ in heart and vascular smooth muscle cells
Jacques, D., Sader, S., El‐Bizri, N., et al. (2000) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-78-2-162 · Cited by 22
Neuropeptide Y Y1 receptor mediated mesenteric vasoconstriction in the pig in vivo
Malmström, R. E. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00128-2 · Cited by 21
Central neuropeptide Y and the sigma ligand, JO 1784, reverse corticotropin‐releasing factor‐induced inhibition of gastric acid secretion in rats
Gué, M., Yoneda, M., Mönnikes, H., et al. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14500.x · Cited by 20
Immunohistochemical mapping of enkephalins, NPY, CGRP, and GRP in the cat amygdala
Marcos, P., Coveñas, R., Narváez, J. Á., et al. (1999) · Peptides · doi:10.1016/s0196-9781(99)00018-2 · Cited by 20
Increase of plasma neuropeptide Y-like immunoreactivity following chronic hypoxia in the rat
Cheng, J., Chen, C.-F., Shum, A. Y., Wang, J., & Chen, H. I. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90105-g · Cited by 19
The involvement of neuropeptide Y in the antimuricide action of noradrenaline injected into the medial amygdala of olfactory bulbectomized rats
Kataoka, Y., Sakurai, Y., Mine, K., et al. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90019-0 · Cited by 19
Habituation of the acoustic startle response following lesion of the medial septal nucleus
Miller, S. W., & Treft, R. L. (1979) · Physiology & Behavior · doi:10.1016/0031-9384(79)90153-7 · Cited by 19
GW1229, a novel neuropeptide Y Y1 receptor antagonist, inhibits the vasoconstrictor effect of neuropeptide Y in the hamster microcirculation
Marcela Bitran, C., Daniels, A. J., & Borić, M. P. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00832-1 · Cited by 19
Neuropeptide FF potentiates the behavioral sensitization to amphetamine and alters the levels of neurotransmitters in the medial prefrontal cortex
Chen, J., Li, J.-Y., Liang, K.-W., et al. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01108-1 · Cited by 18
Structure-activity relationships of a series of 1-substituted-4-methylbenzimidazole neuropeptide Y-1 receptor antagonists
Zimmerman, D. M., Cantrell, B. E., Smith, E. C., Nixon, J. A., Bruns, R. F., Gitter, B. D., Hipskind, P. A., Ornstein, P. L., Zarrinmayeh, H., Britton, T. C., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00048-1 · Cited by 17
Conditioned suppression of medial forebrain bundle and septal intracranial self-stimulation in the rat: Evidence for a fear-relief mechanism of the septum.
Grauer, E., & Thomas, E. (1982) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0077860 · Cited by 17
Orexigenic effect of the melanocortin MC4receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1receptor selective antagonists
Kask, A., Schiöth, H. B., Harro, J., Wikberg, J. E. S., & Rägo, L. (2000) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y99-124 · Cited by 17
Self-citation
A potent nonpeptide neuropeptide Y Y1 receptor antagonist, a benzodiazepine derivative
Shigeri, Y., Ishikawa, M., Ishihara, Y., et al. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00357-9 · Cited by 16
Comparison of neuropeptide Y immunoreactivity in hypothalamic and brainstem nuclei of young and mature spontaneously hypertensive and normotensive Wistar-Kyoto rats
Maccarrone, C., Jarrott, B., & Conway, E. L. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90148-5 · Cited by 16
Iodinated-NPY binding sites: Autoradiographic study in the rat brain
Giardino, L., Calzà, L., Zanni, M., et al. (1989) · Neuropeptides · doi:10.1016/0143-4179(89)90017-6 · Cited by 16
The behavioral effects of lesions of the septum: A review
Chozick, B. S. (1985) · International Journal of Neuroscience · doi:10.3109/00207458508985617 · Cited by 15
Structure—activity analysis of the motor effects of neuropeptide Y
JOLICOEUR, F. B., Bouali, S. M., Michaud, J.-N., et al. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(94)00172-3 · Cited by 14
Neuropeptide Y Y1receptors in the rat forebrain: Autoradiographic demonstration of [125I][Leu31,Pro34]-NPY binding sites and neurons expressing Y1receptor mRNA
Larseni, P. J., Sheikh, S. P., & Mikkelsen, J. D. (1995) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899509045233 · Cited by 14
Centrally administered neuropeptide Y fails to increase food intake but enhances hypoalgesia in spontaneously hypertensive rats
Pich, E. M., Solfrini, V., Marrama, P., et al. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90773-e · Cited by 13
Stimulation of Neuropeptide Y Overflow in the Rat Paraventricular Nucleus by Corticotropin‐Releasing Factor
Morris, M. J., & Pavia, J. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041519.x · Cited by 13
The importance of various parts of the NPY molecule for receptor recognition
Beck‐Sickinger, A. G. (1997) · Elsevier eBooks · doi:10.1016/b978-012304990-2/50007-x · Cited by 12
Monosodium glutamate increases NGF and NPY concentrations in rat hypothalamus and pituitary
Tirassa, P., Lundeberg, T., Stenfors, C., et al. (1995) · Neuroreport · doi:10.1097/00001756-199512150-00003 · Cited by 11
Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide Y Y1 receptor antagonists
Dove, S., Michel, M. C., Knieps, S., et al. (2000) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-78-2-108 · Cited by 7
Neural transplants
Yang, F.-C., Connor, J., Patel, A., et al. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00256-5 · Cited by 5
Localization of dopamine β‐hydroxylase (DBH) and neuropeptide tyrosine (NPY) mRNA in the grey monkey locus coeruleus and adrenal medulla
Dagerlind, Å., & Schalling, M. (1998) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1998.tb08533.x · Cited by 5
Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide Y Y1receptor antagonists
Dove, S., Michel, M. C., Knieps, S., et al. (2000) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y99-120 · Cited by 4
Neuropeptide changes in the suprachiasmatic nucleus in primary hypertension indicate functional impairment of the biological clock
Goncharuk (2001) · Pure Amsterdam UMC · doi:10.1002/1096-9861(20010312)431:3
Untitled work
Matelli (1998) · doi:10.1002/(sici)1096-9861(19981221)402:3

Research works printed but not linked: 5

Dumont, 2000, brains, vol. 16, 375
Hilakivi, 1990, Correlations between behaviour of mice in Porsolt's swim test and in test of anxiety, locomotion, and exploration, Behav Neural Biol, 53
Kask, 2001, Neuropeptide Y Y5 antagonist CGP71683A: effects on food intake and anxiety-related behaviour in the rat, Eur J Pharmacol, 413, 9
Pich, 1990, Effects of central administration of neuropeptide Y on vigilance and pain thresold in spontaneously hypertensive rats, Adv Pain Res Ther, 13, 55
Risold, 1997, Chemoarchitecture of the rat lateral septal nucleus, Brain Res Rev, 24

Sorted by citations

Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress
Charney, D. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.195 · Cited by 1,605
Anxiety, depression, and the microbiome: A role for gut peptides
Lach, G., Schellekens, H., Dinan, T. G., & Cryan, J. F. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0585-0 · Cited by 573
Neuropeptide, Y, peptide YY and pancreatic polypeptide in the gut-brain axis
Holzer, P., Reichmann, F., & Farzi, A. (2012) · Neuropeptides · doi:10.1016/j.npep.2012.08.005 · Cited by 501
Neuropeptide Y: a stressful review
Reichmann, F., & Holzer, P. (2016) · Neuropeptides · doi:10.1016/j.npep.2015.09.008 · Cited by 490
Neuropeptides and the Microbiota-Gut-Brain Axis
Holzer, P., & Farzi, A. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_9 · Cited by 451

See all 358

Authors: Kask, A., Harro, J., von Hörsten, S., Redrobe, J. P., Dumont, Y., & Quirion, R.
Affiliations: National Institute of Chemical Physics and Biophysics (EE)
University of Tartu (EE)
Douglas Mental Health University Institute (CA)
Corresponding author: Kask, Ants
ORCID: Kask, Ants
Harro, Jaanus
Venue: Neuroscience & Biobehavioral Reviews
Publisher: Elsevier BV
Published: 2002-05
Volume: 26
Issue: 3
Pages: 259-283
ISSN: 0149-7634 (ISSN-L)
DOI: 10.1016/s0149-7634(01)00066-5
OpenAlex: W1987735575
Cited by: 358
References: 311
Citations by year: 2026: 6 · 2025: 12 · 2024: 14 · 2023: 12 · 2022: 8 · 2021: 12 · 2020: 13 · 2019: 16 · 2018: 12 · 2017: 10 · 2016: 11 · 2015: 13 · 2014: 21 · 2013: 13 · 2012: 18
FWCI: 2.17
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neuroscience & Biobehavioral Reviews (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: neuropeptide Y, NPY receptors, Y1 receptor, Y2 receptor, Y4 receptor, Y5 receptor, anxiolytic effects, anxiety regulation, neurocircuitry, amygdala, dorsal periaqueductal gray, locus coeruleus, NPY receptor antagonists, arousal
MeSH terms: Animals, Anxiety, Behavior, Animal, Brain, Brain Chemistry, Humans, Neuropeptide Y, Anti-Anxiety Agents, Receptors, Neuropeptide Y, Models, Animal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks